Contact
searchSearch
HMP Global
Login
Conference Insider
Pembrolizumab Plus Chemo Promising for Treatment of NSCLC
03/24/2021
In patients with advanced NSCLC that lack targetable mutations, pembrolizumab combined with chemo has shown promising results, according to research presented at the NCCN annual conference.
In patients with advanced NSCLC that lack targetable mutations, pembrolizumab combined with chemo has shown promising results, according to research presented at the NCCN annual conference.
In patients with advanced NSCLC...
03/24/2021
Oncology
Conference Insider
Improved Survival With Treatment Guided by Biomarker Testing for NSCLC
03/19/2021
Patients with advanced/metastatic NSCLC have improved survival after treatment guided by biomarker testing, according to research presented at the NCCN Annual Conference.
Patients with advanced/metastatic NSCLC have improved survival after treatment guided by biomarker testing, according to research presented at the NCCN Annual Conference.
Patients with...
03/19/2021
Oncology
Conference Insider
Managing Testosterone Levels When Dosing is Delayed for Prostate Cancer
03/19/2021
In a study presented at the NCCN annual congress, Gel-LA was more likely to suppress testosterone rates over an extended period of time than Msphere-LA.
In a study presented at the NCCN annual congress, Gel-LA was more likely to suppress testosterone rates over an extended period of time than Msphere-LA.
In a study presented at the NCCN...
03/19/2021
Oncology
Conference Insider
Important to Control for FN Risks During Comparative Effectiveness Analyses of Breast Cancer, NHL
03/19/2021
Patients with NHL with intermediate risk for FN maintain that risk even with pegfilgrastim prophylaxis, according to research presented at the NCCN Annual Conference.
Patients with NHL with intermediate risk for FN maintain that risk even with pegfilgrastim prophylaxis, according to research presented at the NCCN Annual Conference.
Patients with NHL with...
03/19/2021
Oncology
Conference Insider
Comorbidities in Older Patients With Lymphoma Have Well-Defined Patterns
03/19/2021
Study findings have led experts to suggest that comorbidities in patients with non-Hodgkin’s lymphoma do not present randomly, but have distinct patterns, according to research presented at the NCCN 2021 Virtual Annual Conference.
Study findings have led experts to suggest that comorbidities in patients with non-Hodgkin’s lymphoma do not present randomly, but have distinct patterns, according to research presented at the NCCN 2021 Virtual Annual Conference.
Study findings have led experts...
03/19/2021
Oncology
Conference Insider
DIBH Improves Lung, Liver Parameters in Patients With Breast Cancer
03/18/2021
Findings from a study presented at the NCCN Virtual Annual Congress found that regular DBHI for RNI-rBC improved lung and liver parameters.
Findings from a study presented at the NCCN Virtual Annual Congress found that regular DBHI for RNI-rBC improved lung and liver parameters.
Findings from a study presented...
03/18/2021
Oncology
Conference Insider
ctDNA Could Improve Monitoring of Response to Chemo in ALL
03/18/2021
The current protocol for monitoring the response to chemo in patients with ALL is a bone marrow biopsy, but a better one may exist, according to data presented at the NCCN Annual Conference.
The current protocol for monitoring the response to chemo in patients with ALL is a bone marrow biopsy, but a better one may exist, according to data presented at the NCCN Annual Conference.
The current protocol for...
03/18/2021
Oncology
Conference Insider
Experts Estimate Prevalence of Future FL, DLBCL Cases in the United States, Europe
03/18/2021
Study findings lead experts to suggest that the prevalence of DLBCL and FL will likely rise in the United States and Europe, according to research presented at the NCCN Annual Conference.
Study findings lead experts to suggest that the prevalence of DLBCL and FL will likely rise in the United States and Europe, according to research presented at the NCCN Annual Conference.
Study findings lead experts to...
03/18/2021
Oncology
News
Improving Care and the Management of Patients with Cancer
03/15/2021
From March 18-20, 2021, oncology professionals from a variety of specialties and care delivery settings will convene virtually for the National Comprehensive Cancer Network (NCCN) 2021 Virtual Annual Conference. 
From March 18-20, 2021, oncology professionals from a variety of specialties and care delivery settings will convene virtually for the National Comprehensive Cancer Network (NCCN) 2021 Virtual Annual Conference. 
From March 18-20, 2021, oncology...
03/15/2021
Oncology
Conference Insider
Patients With Cancer Have Higher Risk for Viral Infection
03/12/2021
Patients with cancer were found to have a significantly higher risk for COVID-19 infection and its adverse outcomes, especially in African American patients.
Patients with cancer were found to have a significantly higher risk for COVID-19 infection and its adverse outcomes, especially in African American patients.
Patients with cancer were found...
03/12/2021
Oncology
Interview
Yale Study Shows Treatment Underutilization and Supports NCCN Guideline Recommendations for Patients with PV
01/01/2021
Nikolai Podoltsev, MD, PhD, discusses the underuse of phlebotomy and hydroxyurea in older patients with PV.
Nikolai Podoltsev, MD, PhD, discusses the underuse of phlebotomy and hydroxyurea in older patients with PV.
Nikolai Podoltsev, MD, PhD,...
01/01/2021
Oncology
News
NCCN Updates Guidelines for MDS
07/19/2018
The NCCN has published updates to their clinical practice guidelines for myelodysplastic syndromes, including updates to initial evaluation, additional testing, and prognostic categories.
The NCCN has published updates to their clinical practice guidelines for myelodysplastic syndromes, including updates to initial evaluation, additional testing, and prognostic categories.
The NCCN has published updates...
07/19/2018
Oncology
News
NCCN Updates Guidelines for Lung Cancer Screening
06/13/2018
The National Comprehensive Cancer Network has published updates to their clinical practice guidelines for lung cancer screening.
The National Comprehensive Cancer Network has published updates to their clinical practice guidelines for lung cancer screening.
The National Comprehensive...
06/13/2018
Oncology
News
Adherence to NCCN Guidelines Lacking for Breast Cancer Screening
05/24/2018
Survivors of breast cancer are not getting the recommended level of screening post-surgery.
Survivors of breast cancer are not getting the recommended level of screening post-surgery.
Survivors of breast cancer are...
05/24/2018
Oncology
Commentary
Supportive Care Deemed Critical in NCCN Updated Guidelines for Multiple Myeloma
03/26/2018
Treatment guidelines for multiple myeloma still promote the use of supportive care as a critical component of care.
Treatment guidelines for multiple myeloma still promote the use of supportive care as a critical component of care.
Treatment guidelines for...
03/26/2018
Oncology
Commentary
NCCN Updates Management Guidelines for Myeloproliferative Neoplasms
01/02/2018
The National Comprehensive Cancer Network has released updates to their guidelines for myeloproliferative neoplasms, including management suggestions for related disorders and testing options.
The National Comprehensive Cancer Network has released updates to their guidelines for myeloproliferative neoplasms, including management suggestions for related disorders and testing options.
The National Comprehensive...
01/02/2018
Oncology

The NCCN Annual Conference program covers the latest discoveries across the spectrum of cancer research and highlights the work of the best minds in research and medicine from institutions all over the world.

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use